CoChat

A dose-finding and discontinuation study of clomipramine in panic disorder

Lotufo-Neto, Francisco, Bernik, Márcio, Ramos, Renato T., Andrade, Laura, Gorenstein, Clarice, Cordás, Taki, Melo, Márcio, Gentil, Valentim · 2001 · Journal of Psychopharmacology

The DOI matches its Crossref record; 57 of the 58 references it cites were found in a registry or an index.

Abstract

Eighty-one panic disorder patients with or without agoraphobia were treated with flexible doses of clomipramine under single-blind conditions. Fifty-seven (70.3%) reached operational criteria for full remission in 16.2 ± 6.5 weeks, with a mean dose of 89.1 ± 8.2 mg/day. Fifty-four (81%) of them received a continuous post-remission maintenance treatment at full doses of clomipramine for 4–6 months. No patient relapsed during the clomipramine maintenance phase. Their medication was then tappered and discontinued with placebo substitution under double-blind conditions. Fifty-one (63%) patients were followed-up until relapse or recurrence for up to 3 years, with periodic assessments. Three different outcome groups were identified: the first (n = 19, 19; 37.2%) experienced an early/immediate relapse (5.2 ± 4.9 weeks after drug discontinuation); the second group (n= 22, 22; 43.1%) experienced recurrence after 42.9 ± 35 weeks following discontinuation; and the third group (n = 10, 10; 19.6%) remained assymptomatic and functionally well throughout the follow-up. Predictors of early relapse were: (1) higher baseline score in the Beck Depression Inventory; (2) higher global score on the phobic avoidance scale after the full remission criteria; and (3) the need for higher clomipramine doses to reach full remission. The need for long-term or intermittent maintenance for most patients is emphasized.

Overview

Integrity signals

Registry

Crossref · 10.1177/026988110101500103

Cites

57 of 57 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 57 references

Research works printed but not linked: 16

  1. Ballenger J C, 1992, J Clin Psychiatry, 53, 26
  2. Ballenger J C, 1993, Psychopharmacol Bull, 29, 477
  3. Ballenger J C, 1993, J Clin Psychiatry, 54, 15
  4. Dager S R, 1990, Psychopharmacol Bull, 26, 273
  5. Fyer A J, 1987, Am J Psychiatry, 143, 303
  6. Gentil V, 1986, Rev Assoc Med Brasil, 32, 101
  7. Gorman J M, 1990, J Clin Psychiatry, 51, 11
  8. Kupfer D J, 1991, J Clin Psychiatry, 52, 12
  9. Leonard B E, 1993, J Clin Psychiatry, 54, 3
  10. Maddock R J, 1993, J Clin Psychiatry, 54, 88
  11. Nagy L M, 1993, J Clin Psychopharmacol, 13, 16
  12. Noyes R Jr, 1989, J Clin Psychiatry, 50, 163
  13. Noyes R Jr, 1990, J Clin Psychiatry, 51, 24
  14. Pollack M H, 1990, J Clin Psychiatry, 51, 11
  15. Pollack M H, 1997, J Clin Psychiatry, 52, 57
  16. Rosenbaum JF, 1997, J Clin Psychiatry, 58, 3

Cited by

See all 27

Metadata

Authors
Lotufo-Neto, F., Bernik, M., Ramos, R. T., Andrade, L., Gorenstein, C., Cordás, T., Melo, M., & Gentil, V.
Affiliations
  • Institute of Psychiatry and Departament of Psychiatry, University of São Paulo Medical School, Brazil; Caixa Postal 3671 Departamento de Psiquiatria 01060—970 São Paulo Brazil;
  • Universidade de São Paulo (BR)
Venue
Journal of Psychopharmacology
Published
2001-01
Volume
15
Issue
1
Pages
13-17
ISSN
  • 0269-8811 (ISSN-L)
  • 1461-7285
OpenAlex
W1977727006
Cited by
27
References
58
Citations by year
2020: 2 · 2013: 1 · 2012: 1
FWCI
4.97
Type
journal article
Language
en
Open access
closed
Licence
journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
Locations
  • Journal of Psychopharmacology (publishedVersion)
  • PubMed (publishedVersion)
Funders
Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
Topics
  • Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
  • Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
  • Social Sciences › Psychology › Clinical Psychology › Psychological Treatments and Disorders
Keywords
clomipramine, panic disorder, agoraphobia, dose-finding, drug discontinuation, recurrence prediction, maintenance therapy, tapering, predictors of relapse, phobic avoidance
MeSH terms
Adolescent, Adult, Antidepressive Agents, Tricyclic, Clomipramine, Dose-Response Relationship, Drug, Double-Blind Method, Female, Humans, Male, Middle Aged, Psychiatric Status Rating Scales, Recurrence, Single-Blind Method, Panic Disorder

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: A dose-finding and discontinuation study of clomipramine in panic disorder. https://app.cochat.ai/papers/10.1177/026988110101500103
The paper
Lotufo-Neto, F., Bernik, M., Ramos, R. T., Andrade, L., Gorenstein, C., Cordás, T., Melo, M., & Gentil, V. (2001). A dose-finding and discontinuation study of clomipramine in panic disorder. Journal of Psychopharmacology. https://doi.org/10.1177/026988110101500103

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.